(2Z,3E)-3-((2-(1-Methylpiperidin-2-yl)ethoxy)imino)-[2,3'-biindolinylidene]-2'-one

ID: ALA5173181

PubChem CID: 168271502

Max Phase: Preclinical

Molecular Formula: C25H27N3O2

Molecular Weight: 401.51

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCCCC1CCO/N=C1C(=C2/C(=O)Nc3ccccc32)/Cc2ccccc2/1

Standard InChI:  InChI=1S/C25H27N3O2/c1-28-14-7-6-9-18(28)13-15-30-27-24-19-10-3-2-8-17(19)16-21(24)23-20-11-4-5-12-22(20)26-25(23)29/h2-5,8,10-12,18H,6-7,9,13-16H2,1H3,(H,26,29)/b23-21+,27-24+

Standard InChI Key:  QPVIMKGAARTVTE-BTYMCAMKSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -1.9525   -1.3869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6671   -1.7992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6671   -2.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9507   -3.0357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2406   -2.6239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4577   -2.8698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0342   -2.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8595   -2.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4146   -2.8066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2010   -3.6037    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1744   -2.4745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0935   -1.6730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6671   -1.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4122   -0.2494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5944   -0.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0230   -0.6858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2721   -1.4876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4364   -1.5486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2406   -1.7987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2229   -0.7514    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8063   -0.1680    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5928    0.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1762    1.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9627    2.0095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5462    2.5930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3326    3.3901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5356    3.6037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0478    3.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1656    2.2231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4178    1.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  8  7  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 12 11  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 17 16  1  0
 17 12  2  0
 17  8  1  0
 18  7  1  0
 19 18  1  0
 19  1  1  0
  5 19  2  0
 18 20  2  0
 20 21  1  0
 22 21  1  0
 22 23  1  0
 23 24  1  0
 25 24  1  0
 26 25  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 24 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5173181

    ---

Associated Targets(Human)

TLK2 Tchem Serine/threonine-protein kinase tousled-like 2 (710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ASF1A Tchem Histone chaperone ASF1A (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMR-90 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.51Molecular Weight (Monoisotopic): 401.2103AlogP: 4.24#Rotatable Bonds: 4
Polar Surface Area: 53.93Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.24CX Basic pKa: 9.60CX LogP: 4.05CX LogD: 2.03
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.47Np Likeness Score: -0.06

References

1. Lee SB, Chang TY, Lee NZ, Yu ZY, Liu CY, Lee HY..  (2022)  Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinases.,  227  [PMID:34662748] [10.1016/j.ejmech.2021.113904]

Source